advertisement
Frontiers in molecular biosciences 11
Showing records 1 to 11 |
Display all abstracts in Frontiers in molecular biosciences121566 Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucomaKannan V
Frontiers in molecular biosciences 2024; 11: 1421030
120627 Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopiaBelete GT
Frontiers in molecular biosciences 2024; 11: 1403844
121566 Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucomaSrimadh Bhagavatham SK
Frontiers in molecular biosciences 2024; 11: 1421030
120627 Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopiaZhou L
Frontiers in molecular biosciences 2024; 11: 1403844
121566 Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucomaDandamudi RB
Frontiers in molecular biosciences 2024; 11: 1421030
120627 Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopiaLi KK; So PK
Frontiers in molecular biosciences 2024; 11: 1403844
121566 Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucomaKunchala H
Frontiers in molecular biosciences 2024; 11: 1421030
120627 Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopiaDo CW
Frontiers in molecular biosciences 2024; 11: 1403844
121566 Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucomaChalla S
Frontiers in molecular biosciences 2024; 11: 1421030
120627 Metabolomics studies in common multifactorial eye disorders: a review of biomarker discovery for age-related macular degeneration, glaucoma, diabetic retinopathy and myopiaLam TC
Frontiers in molecular biosciences 2024; 11: 1403844
121566 Integrated clinical and metabolomic analysis identifies molecular signatures, biomarkers, and therapeutic targets in primary angle closure glaucomaAlmansour AI; Pargaonkar A; Pulukool SK; Sharma A; Sivaramakrishnan V
Frontiers in molecular biosciences 2024; 11: 1421030